ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/06/07 | 2,093 | 2,110 | 2,090 | 2,102 | +9 | +0.4% | 63,200 |
2021/06/04 | 2,104 | 2,104 | 2,083 | 2,093 | -11 | -0.5% | 54,500 |
2021/06/03 | 2,077 | 2,125 | 2,076 | 2,104 | +12 | +0.6% | 69,600 |
2021/06/02 | 2,100 | 2,104 | 2,066 | 2,092 | -14 | -0.7% | 156,100 |
2021/06/01 | 2,106 | 2,112 | 2,099 | 2,106 | +14 | +0.7% | 74,900 |
2021/05/31 | 2,109 | 2,125 | 2,088 | 2,092 | -20 | -0.9% | 111,100 |
2021/05/28 | 2,069 | 2,113 | 2,069 | 2,112 | +44 | +2.1% | 67,000 |
2021/05/27 | 2,062 | 2,105 | 2,062 | 2,068 | -12 | -0.6% | 165,200 |
2021/05/26 | 2,041 | 2,083 | 2,037 | 2,080 | +30 | +1.5% | 79,800 |
2021/05/25 | 2,045 | 2,054 | 2,040 | 2,050 | +5 | +0.2% | 73,500 |
2021/05/24 | 2,032 | 2,048 | 2,024 | 2,045 | +13 | +0.6% | 35,700 |
2021/05/21 | 2,022 | 2,041 | 2,022 | 2,032 | +10 | +0.5% | 46,900 |
2021/05/20 | 2,016 | 2,032 | 2,015 | 2,022 | +6 | +0.3% | 39,100 |
2021/05/19 | 1,995 | 2,016 | 1,990 | 2,016 | -5 | -0.2% | 55,600 |
2021/05/18 | 2,009 | 2,028 | 2,007 | 2,021 | +12 | +0.6% | 49,400 |
2021/05/17 | 2,006 | 2,022 | 2,006 | 2,009 | -1 | ±0% | 58,100 |
2021/05/14 | 2,000 | 2,025 | 2,000 | 2,010 | +11 | +0.6% | 76,200 |
2021/05/13 | 2,003 | 2,013 | 1,989 | 1,999 | -4 | -0.2% | 138,800 |
2021/05/12 | 2,018 | 2,022 | 1,993 | 2,003 | +3 | +0.2% | 152,500 |
2021/05/11 | 2,005 | 2,018 | 1,988 | 2,000 | -11 | -0.5% | 66,900 |
2021/05/10 | 1,981 | 2,016 | 1,980 | 2,011 | +38 | +1.9% | 28,300 |
2021/05/07 | 1,978 | 1,979 | 1,968 | 1,973 | +12 | +0.6% | 27,000 |
2021/05/06 | 1,956 | 1,980 | 1,956 | 1,961 | +7 | +0.4% | 42,700 |
2021/04/30 | 1,951 | 1,970 | 1,950 | 1,954 | -2 | -0.1% | 49,600 |
2021/04/28 | 1,980 | 1,981 | 1,956 | 1,956 | -32 | -1.6% | 58,300 |
2021/04/27 | 2,003 | 2,009 | 1,988 | 1,988 | -25 | -1.2% | 48,400 |
2021/04/26 | 2,016 | 2,020 | 1,994 | 2,013 | -3 | -0.1% | 58,100 |
2021/04/23 | 2,031 | 2,034 | 2,012 | 2,016 | -9 | -0.4% | 25,800 |
2021/04/22 | 2,038 | 2,051 | 2,017 | 2,025 | +8 | +0.4% | 34,300 |
2021/04/21 | 2,015 | 2,019 | 2,001 | 2,017 | +2 | +0.1% | 64,600 |
2021/04/20 | 2,013 | 2,022 | 2,000 | 2,015 | -20 | -1% | 50,000 |
2021/04/19 | 2,065 | 2,073 | 2,035 | 2,035 | -18 | -0.9% | 31,600 |
2021/04/16 | 2,069 | 2,073 | 2,052 | 2,053 | -13 | -0.6% | 19,300 |
2021/04/15 | 2,048 | 2,066 | 2,046 | 2,066 | +14 | +0.7% | 29,400 |
2021/04/14 | 2,040 | 2,052 | 2,033 | 2,052 | +10 | +0.5% | 43,300 |
2021/04/13 | 2,048 | 2,063 | 2,042 | 2,042 | -13 | -0.6% | 61,900 |
2021/04/12 | 2,063 | 2,063 | 2,050 | 2,055 | -3 | -0.1% | 48,800 |
2021/04/09 | 2,047 | 2,069 | 2,037 | 2,058 | +11 | +0.5% | 49,100 |
2021/04/08 | 2,060 | 2,066 | 2,041 | 2,047 | -25 | -1.2% | 65,600 |
2021/04/07 | 2,052 | 2,074 | 2,036 | 2,072 | +16 | +0.8% | 54,300 |
2021/04/06 | 2,086 | 2,099 | 2,036 | 2,056 | -31 | -1.5% | 64,800 |
2021/04/05 | 2,098 | 2,098 | 2,075 | 2,087 | -17 | -0.8% | 45,300 |
2021/04/02 | 2,133 | 2,133 | 2,085 | 2,104 | +10 | +0.5% | 38,300 |
2021/04/01 | 2,100 | 2,103 | 2,070 | 2,094 | -9 | -0.4% | 43,900 |
2021/03/31 | 2,164 | 2,168 | 2,102 | 2,103 | -86 | -3.9% | 59,600 |
2021/03/30 | 2,256 | 2,270 | 2,180 | 2,189 | -99 | -4.3% | 95,700 |
2021/03/29 | 2,257 | 2,309 | 2,252 | 2,288 | +81 | +3.7% | 245,900 |
2021/03/26 | 2,187 | 2,214 | 2,180 | 2,207 | +29 | +1.3% | 62,500 |
2021/03/25 | 2,208 | 2,219 | 2,174 | 2,178 | +6 | +0.3% | 60,700 |
2021/03/24 | 2,240 | 2,240 | 2,165 | 2,172 | -41 | -1.9% | 59,300 |
851~
900
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム